P4–410: Steady–state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease are not affected by co–administration of memantine

التفاصيل البيبلوغرافية
العنوان: P4–410: Steady–state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease are not affected by co–administration of memantine
المؤلفون: Sandeep Athalye, Greg Sedek, Picard Frank, Françoise Pommier, Juanita Smith, Joshua R. Shua-Haim, Gilbert Lefèvre
المصدر: Alzheimer's & Dementia. 2
بيانات النشر: Wiley, 2006.
سنة النشر: 2006
مصطلحات موضوعية: Rivastigmine, biology, Epidemiology, business.industry, Health Policy, Memantine, Disease, Pharmacology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Pharmacokinetics, medicine, biology.protein, In patient, Neurology (clinical), Steady state (chemistry), Geriatrics and Gerontology, business, medicine.drug, Co administration, Cholinesterase
الوصف: Background and objective: It has been shown that combining memantine and a cholinesterase inhibitor, which each affect different neurotransmitter systems, may offer further improvements in efficacy over either treatment alone in patients with Alzheimer’s disease. The present study was conducted to determine if memantine has any effects on the steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer’s disease.
تدمد: 1552-5279
1552-5260
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::715b8eaf4ebd70d6955448eacb030b83
https://doi.org/10.1016/j.jalz.2006.05.2152
حقوق: OPEN
رقم الأكسشن: edsair.doi...........715b8eaf4ebd70d6955448eacb030b83
قاعدة البيانات: OpenAIRE